Vimarsana
Biggest News Aggregation in the World

Page 2 - Aragen Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aragen Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aragen Bioscience Today - Breaking & Trending Today

Global Antibody Discovery Services and Platforms Market Research Report 2022: Extensive Study on the Current Market Landscape and Likely Evolution in this Industry Over the Next Ten Years - Vimarsana News

Global Antibody Discovery Services and Platforms Market Research Report 2022: Extensive Study on the Current Market Landscape and Likely Evolution in this Industry Over the Next Ten Years

/PRNewswire/ -- The "Antibody Discovery Services and Platforms Market: Distribution by Type of Service Offered, Antibody Discovery Method, Nature of Antibody...

Aragen Life Sciences: Goldman Sachs buys stake in contract research firm Aragen Life Sciences - Vimarsana News

Aragen Life Sciences: Goldman Sachs buys stake in contract research firm Aragen Life Sciences

Synopsis Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platforms. The company serves a worldwide customer base which spans to the United States, Europe, and Japan. Wall Street behemoth Goldman Sachs has taken a significant minority stake in Aragen Life Sciences, formerly known as GVK Biosciences, a leading contract research organization (CRO), the company announced today. Goldman Sachs, an active investor in India, has acquired shares previously held by ChrysCapital and other existing shareholders. The priva...

Goldman Sachs Asset Management Buys Minority Stake in Aragen Life Sciences - Vimarsana News

Goldman Sachs Asset Management Buys Minority Stake in Aragen Life Sciences

Aragen Life Sciences Pvt Ltd (formerly known as GVK Biosciences) is a company that works in discovery, development, and manufacturing solutions. They offer differentiated contract research organization (CRO) and contract development and manufacturing organization (CDMO) solutions for small and large molecules. The private equity arm of Goldman Sachs Asset Management acquired a significant 33% minority […]

Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates - Vimarsana News

Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates

Monopar Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Updates First Patient Dosed in Validive ® Camsirubicin Run-in Clinical Trial Now Planned to Start in 2H 2021 Potential Utility Reported for MNPR-101 as Imaging Agent in Cancer Surgery WILMETTE, Ill., May 13, 2021 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced first quarter 2021 ...

PDX Models Market 2021 Latest Trends and Developments – Crown Bioscience, THE JACKSON LABORATORY, Champions Oncology – KSU - Vimarsana News

PDX Models Market 2021 Latest Trends and Developments – Crown Bioscience, THE JACKSON LABORATORY, Champions Oncology – KSU

26 Data Bridge Market Research has recently added a new research report to its mega database of research international studies. The research report, titled “PDX Models Market 2021” identifies and analyses the emerging trends along with major drivers, challenges market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels and opportunities in the market for PDX Models industry. For a thriving business, it is quite essential to get know how of consumer’s demands, preferences, attitudes and their changing ...